New Delhi, Feb. 24 -- Mankind Pharma, India's fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off-patent early next year.

The pharma major is the latest among the country's top generics drugmakers, including Dr. Reddy's Laboratories and Natco Pharma, to explore a potential launch of the drug, and is banking on partnerships and its strong market presence to gain an edge, a senior executive told Mint in an interview.

"Obesity is the market everybody wants to look at, it's a very, very big market opening up.we are no exception to that," Atish Majumdar, senior president at Mankind Pharma, told Mint. "We are also keenly lookin...